Market revenue in 2023 | USD 102,215.6 million |
Market revenue in 2030 | USD 191,191.2 million |
Growth rate | 9.4% (CAGR from 2023 to 2030) |
Largest segment | Contract manufacturing |
Fastest growing segment | Contract Manufacturing |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Contract Development, Contract Manufacturing |
Key market players worldwide | Catalent Inc, Lonza Group Ltd, Recipharm, Siegfried Holding AG, Thermo Fisher Scientific Inc, Labcorp Drug Development, Jabil Inc, Syngene, IQVIA Holdings Inc, Almac Group, Ajinomoto Co Inc, Alcami, Vetter Pharma-Fertigung |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to healthcare contract development and manufacturing organization market will help companies and investors design strategic landscapes.
Contract manufacturing was the largest segment with a revenue share of 64.79% in 2023. Horizon Databook has segmented the North America healthcare contract development and manufacturing organization market based on contract development, contract manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
North America is one of the major contributors to the growth of healthcare contract development & manufacturing organization market. It is characterized by the presence of several established biotechnology, pharmaceutical, and medical device companies.
Furthermore, growing R&D investments by life sciences and pharmaceutical companies are anticipated to increase the demand for contract manufacturing in the region. In addition, stringent regulations on manufacturing and quality of products are anticipated to create growth opportunities for domestic contract manufacturing services.
Rapid growth in medical devices manufacturing, to meet the high demand for efficient healthcare in the region, is expected to be one of the major factors contributing to market growth in North America. The development of cost-effective medical device equipment is likely to have a positive impact on the market during the forecast period.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America healthcare contract development and manufacturing organization market , including forecasts for subscribers. This continent databook contains high-level insights into North America healthcare contract development and manufacturing organization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account